Lower extremity ulcers in systemic sclerosis: Features and response to therapy

International Journal of Rheumatology

Volumn 2010, Issue , 2010, Pages

  Shanmugam, Victoria K ^a   Price, Patricia ^b   Attinger, Christopher E ^a   Steen, Virginia D ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ANTIBODY; BLOOD CLOTTING FACTOR 5 LEIDEN; CENTROMERE ANTIBODY; ENOXAPARIN; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PENTOXIFYLLINE; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN; RNA POLYMERASE III ANTIBODY; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; BIOPSY; BLEEDING; CLINICAL ARTICLE; CLINICAL FEATURE; DIFFUSE SCLERODERMA; DISEASE COURSE; DISEASE DURATION; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; GENE MUTATION; GENETIC SCREENING; HUMAN; IMMUNOASSAY; LEG ULCER; LOW DRUG DOSE; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; SYSTEMIC SCLEROSIS; UNIVERSITY HOSPITAL;

EID: 79955111933     PISSN: 16879260     EISSN: 16879279     Source Type: Journal    
DOI: 10.1155/2010/747946     Document Type: Article

References (26)

1. Reidy M. E., Steen V., Nicholas J. J., Lower extremity amputation in scleroderma Archives of Physical Medicine and Rehabilitation 1992 73 9 811 813
2. Alivernini S., De Santis M., Tolusso B., Mannocci A., Bosello S. L., Peluso G., Pinnelli M., D'Antona G., LaTorre G., Ferraccioli G., Skin ulcers in systemic sclerosis: determinants of presence and predictive factors of healing Journal of the American Academy of Dermatology 2009 60 3 426 435
3. Ramsey S. D., Newton K., Blough D., McCulloch D. K., Sandhu N., Reiber G. E., Wagner E. H., Incidence, outcomes, and cost of foot ulcers in patients with diabetes Diabetes Care 1999 22 3 382 387 (Pubitemid 29106890)
4. Hafner J., Schneider E., Burg G., Cassina P. C., Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease Journal of Vascular Surgery 2000 32 2 322 329 (Pubitemid 30644947)
5. Milstone L. M., Braverman I. M., Lucky P., Fleckman P., Classification and therapy of atrophie blanche Archives of Dermatology 1983 119 12 963 969 (Pubitemid 14203354)
6. Miura T., Torinuki W., Clinical course of atrophie blanche Journal of Dermatology 1977 4 6 259 262 (Pubitemid 8276035)
7. Hairston B. R., Davis M. D. P., Pittelkow M. R., Ahmed I., Livedoid vasculopathy: further evidence for procoagulant pathogenesis Archives of Dermatology 2006 142 11 1413 1418 (Pubitemid 44790634)
8. Heine K. G., Davis G. W., Idiopathic atrophie blanche: treatment with low-dose heparin Archives of Dermatology 1986 122 8 855 856 (Pubitemid 16039426)
9. Hairston B. R., Davis M. D. P., Gibson L. E., Drage L. A., Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases Archives of Dermatology 2003 139 8 987 990 (Pubitemid 36994821)
10. Jetton R. L., Lazarus G. S., Minidose heparin therapy for vasculitis of atrophie blanche Journal of the American Academy of Dermatology 1983 8 1 23 26 (Pubitemid 13221133)
11. Salmon J. E., Girardi G., Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation Journal of Reproductive Immunology 2008 77 1 51 56
12. Girardi G., Redecha P., Salmon J. E., Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation Nature Medicine 2004 10 11 1222 1226 (Pubitemid 39540439)
13. Shanmugam V. K., Steen V. D., Cupps T. R., Lower extremity ulcers in connective tissue disease Israel Medical Association Journal 2008 10 7 534 536
14. Attinger C. E., Janis J. E., Steinberg J., Schwartz J., Al-Attar A., Couch K., Clinical approach to wounds: debridement and wound bed preparation including the use of dressings and wound-healing adjuvants Plastic Reconstructive Surgery 2006 117 7S 72S 109S (Pubitemid 44317773)
15. Ferri C., Giuggioli D., Sebastiani M., Colaci M., Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin Clinical and Experimental Dermatology 2007 32 3 287 290 (Pubitemid 46495793)
16. Hudson M., Thombs B. D., Steele R., Panopalis P., Newton E., Baron M., Pope J., Markland J., Robinson D., Jones N., Khalidi N., Kaminska E., Docherty P., Abu-Hakima M., Leclercq S., Fritzler M., Masetto A., Smith D., Sutton E., Mathieu J.-P., Health-related quality of life in systemic sclerosis: a systematic review Arthritis Care Research 2009 61 8 1112 1120
17. Speight J., Reaney M. D., Barnard K. D., Not all roads lead to Rome: a review of quality of life measurement in adults with diabetes Diabetic Medicine 2009 26 4 315 327
18. Price P., Harding K., Cardiff Wound Impact Schedule: the development of a condition-specific questionnaire to assess health-related quality of life in patients with chronic wounds of the lower limb International Wound Journal 2004 1 1 10 17
19. Miyakis S., Lockshin M. D., Atsumi T., Branch D. W., Brey R. L., Cervera R., Derkesen R. H. W. M., De Groot P. G., Koike T., Meroni P. L., Reber G., Shoenfeld Y., Tincani A., Vlachoyiannopoulos P. G., Krilis S. A., International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) Journal of Thrombosis and Haemostasis 2006 4 2 295 306
20. Merkel P. A., Chang Y., Pierangeli S. S., Convery K., Harris E. N., Polisson R. P., The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases The American Journal of Medicine 1996 101 6 576 583 (Pubitemid 27150034)
21. Schoenroth L., Fritzler M., Lonzetti L., Sencal J.-L., Antibodies to 2 glycoprotein I and cardiolipin in SSc Annals of the Rheumatic Diseases 2002 61 2 183a 184
22. Parodi A., Drosera M., Barbieri L., Rebora A., Antiphospholipid antibody system in systemic sclerosis Rheumatology 2001 40 1 111 112 (Pubitemid 32124060)
23. Zandman-Goddard G., Tweezer-Zaks N., Shalev T., Levy Y., Ehrenfeld M., Langevitz P., A novel overlap syndrome Annals of the New York Academy of Sciences 2007 1108 497 504
24. Szamosi S., Csiki Z., Szomjk E., Szolnoki E., Szoke G., Szekanecz Z., Szegedi G., Shoenfeld Y., Szucs G., Plasma homocysteine levels, the prevalence of methylenetetrahydrofolate reductase gene C677T polymorphism and macrovascular disorders in systemic sclerosis: risk factors for accelerated macrovascular damage? Clinical Reviews in Allergy and Immunology 2009 36 2-3 145 149
25. Kobashi G., Ohta K., Yamada H., Hata A., Minakami H., Sakuragi N., Tamashiro H., Fujimoto S., 4G/5G variant of plasminogen activator inhibitor-1 gene and severe pregnancy-induced hypertension: subgroup analyses of variants of angiotensinogen and endothelial nitric oxide synthase Journal of Epidemiology 2009 19 6 275 280
26. Arcasoy M. O., The non-haematopoietic biological effects of erythropoietin British Journal of Haematology 2008 141 1 14 31 (Pubitemid 351347536)